Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 6Neoplasms 4Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Radiation Injuries 2Osteosarcoma 2Melanoma 2Lung Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Cognitive Dysfunction 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Thoracic Neoplasms 1Testicular Neoplasms 1Substance-Related Disorders 1Stomach Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Kaposi 1

Interventions

atezolizumab 5avelumab 4erdafitinib 1enfortumab vedotin 1darolutamide 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy 1Patient Reported Outcome Measures 1Nivolumab 1Mitomycin 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Immunotherapy 1Histocompatibility Testing 1High-Throughput Nucleotide Sequencing 1Hematologic Tests 1Gemcitabine 1Focus Groups 1Educational Status 1Drug Therapy 1Defecation 1Cytological Techniques 1Cystoscopy 1Cisplatin 1Carboxylesterase 1Blood Cell Count 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Transitional Cell × Patient Reported Outcome Measures × Clear all
NCT04146064 2026-05-08

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

University Health Network, Toronto

Completed
190 enrolled
DermatologicGenitourinaryHead & Neck

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡